NCT05688293 Gingival Recession (RT1) Treatment With Different Gingival Augmentation Surgeries
| NCT ID | NCT05688293 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Misr International University |
| Condition | Gingival Recession |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2025-02-05 |
| Primary Completion | 2026-01-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2025-02-05 with a primary completion date of 2026-01-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Thin gingival phenotype is one of the major causative factors of gingival recession type 1 which can result in hypersensitivity, discomfort, and compromised esthetics. This study assess the efficacy of increasing the gingival thickness from thin gingival phenotype to thick gingival phenotype in the treatment of patients suffering from gingival recession (RT1) and maintenance of results using either connective tissue graft or de-epithelized free gingival graft after non-surgical periodontal debridement compared to non-surgical periodontal debridement alone.
Eligibility Criteria
Inclusion Criteria: * Medically free patients (American Society of Anesthesiologists I; ASA I) * Patients diagnosed with recession (RT1) * Fair oral hygiene * Patient accepting to provides an informed consent and the follow-up Exclusion Criteria: * Carious teeth and teeth with periapical infection. * Patients diagnosed with periodontitis * Smokers * Pregnant and lactating females
Contact & Investigator
Zainab Hafez, Lecturer
PRINCIPAL INVESTIGATOR
Lecturer, faculty of oral and dental medicine misr international university
Frequently Asked Questions
Who can join the NCT05688293 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 55 Years, studying Gingival Recession. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05688293 currently recruiting?
Yes, NCT05688293 is actively recruiting participants. Contact the research team at zeinab.hafez@miuegypt.edu.eg for enrollment information.
Where is the NCT05688293 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT05688293 clinical trial?
NCT05688293 is sponsored by Misr International University. The principal investigator is Zainab Hafez, Lecturer at Lecturer, faculty of oral and dental medicine misr international university. The trial plans to enroll 30 participants.